First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845
Clinical trial NCT03054402 · COMPLETED
Trial details
- NCT number
- NCT03054402
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-13
- Primary completion
- 2017-11-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.